Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,069
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
for
Stroke, Hemiparesis
Location: Boston MA
Sponsor: Spaulding Rehabilitation Hospital
Sex: All
Age: 21 - 70+
Code: NCT02896348
Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Location: Boston MA, Hartford CT, New Haven CT, Port Jefferson NY,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Boston MA, Concord NH, Albany NY, New York NY,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
for
Obesity With Diabetes, Overweight With Diabetes
Location: Boston MA, East Greenwich RI, Stamford CT, Albany NY,
Sponsor: Kailera
Sex: All
Age: 18+
Code: NCT07284901
Phase3, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: Boston MA, New York NY, New Brunswick NJ, Hershey PA,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase2, Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
for
Diffuse Intrinsic Pontine Glioma,
Location: Boston MA, Hackensack NJ, New York NY, Philadelphia PA,
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 39
Code: NCT05009992
Phase2, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, New Brunswick NJ, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
for
Breast Cancer, Breast Cancer Metastatic,
Location: Boston MA, Buffalo NY, Canton OH, Durham NC, Detroit MI,
Sponsor: Incyclix Bio
Sex: All
Age: 18+
Code: NCT05735080
Phase1, Phase2, Recruiting
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Boston MA, Milford MA, Cromwell CT, Elmhurst NY,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07474792
Phase2, Recruiting
Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline
for
Chronic Pain, Physical Activity, Older Adults,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 50+
Code: NCT06246929
Recruiting
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
for
Sarcoid, Cardiovascular Diseases, Cancer
Location: Boston MA
Sponsor: Ralph Weissleder, MD
Sex: All
Age: 18 - 70+
Code: NCT04843891
Phase1, Recruiting
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
for
Small Cell Lung Cancer, Advanced Solid Malignant Tumor
Location: Boston MA, Fairfax VA, Canton OH, Detroit MI,
Sponsor: Chipscreen Biosciences, Ltd.
Sex: All
Age: 18+
Code: NCT05271292
Phase1, Phase2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy